Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1226P is a pseudogene member of the U6 small nuclear RNA family, annotated in the HGNC database (HGNC:48189), with NCBI Gene ID: 106480102 and Ensembl ID: ENSG00000207044[3][5][7][8]. Pseudogenes are non-functional genomic sequences derived from formerly functional genes, and RNU6-1226P does not encode a functional RNA or protein product. Unlike canonical U6 snRNA members—which play a role in mRNA splicing within the spliceosome[2]—pseudogenes such as RNU6-1226P have no confirmed biological function, clinical relevance, or role as therapeutic targets. There are no known disease associations, interacting drugs, or biomarker utility[8]. Key points: - Not a protein or receptor target: This gene encodes a non-coding RNA; as a pseudogene, it is not functionally involved in canonical biological processes or relevant as a drug target[8]. - No known disease or drug associations: There is no evidence linking RNU6-1226P to diseases, nor is it a biomarker or a safety concern[8]. - Proper annotation: The entry matches the officially recognized nomenclature, with no obvious errors or misinformation[7][8]. - No direct relevance to drug development or clinical application: If searching for a true therapeutic target, consider genuine U6 snRNA genes (such as RNU6-1) involved in the spliceosome, not this pseudogene variant[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1226, pseudogene (RNU6-1226P).